Pluri (PLUR) Interest Expenses (2011 - 2025)
Pluri (PLUR) posted quarterly Interest Expenses of $231000.0 for Q4 2025, up 9.48% year-over-year from $211000.0 in Q4 2024, and up 0.87% quarter-over-quarter from $229000.0 in Q3 2025.
Pluri (PLUR) Interest Expenses (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Interest Expenses for 15 consecutive years, with $231000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Expenses rose 9.48% year-over-year to $231000.0; the TTM figure through Dec 2025 stood at $905000.0 (up 4.99% YoY), while the FY2025 annual figure was $72.2 million, up 8232.91% from the prior year.
- Interest Expenses improved to $231000.0 in Q4 2025 per PLUR's latest filing, from $229000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $970000.0 in Q2 2022 and bottomed at $158000.0 in Q2 2021.
- Historically, Interest Expenses has averaged $260400.0 across 5 years, with a median of $217500.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest Expenses surged 513.92% — and 2023, when it tumbled 77.32%.
- Pluri's Interest Expenses stood at $225000.0 in 2021, then declined by 5.78% to $212000.0 in 2022, then climbed by 1.89% to $216000.0 in 2023, then retreated by 2.31% to $211000.0 in 2024, then rose by 9.48% to $231000.0 in 2025.
- Business Quant data shows PLUR's Interest Expenses at $231000.0 in Q4 2025, $229000.0 in Q3 2025, and $233000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 231,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 231,000.00 |
| Dec 31, 2025 | 231,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Jun 30, 2025 | 233,000.00 |
| Mar 31, 2025 | 212,000.00 |
| Mar 31, 2025 | 212,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Dec 31, 2023 | 216,000.00 |
| Dec 31, 2023 | 216,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Sep 30, 2023 | 214,000.00 |